First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

10.1158/2159-8290.CD-20-0868

Saved in:

Bibliographic Details
Main Authors:	Yap, Timothy A, Tan, David SP, Terbuch, Angelika, Caldwell, Reece, Guo, Christina, GOH BOON CHER, Heong, Valerie, Haris, Noor R Md, Bashir, Saira, Drew, Yvette, Hong, David S, Meric-Bernstam, Funda, Wilkinson, Gary, Hreiki, Joseph, Wengner, Antje M, Bladt, Friedhelm, Schlicker, Andreas, Ludwig, Matthias, Zhou, Yinghui, Liu, Li, Bordia, Sonal, Plummer, Ruth, Lagkadinou, Eleni, de Bono, Johann S
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	American Association for Cancer Research. 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology DNA-DAMAGE PROSTATE-CANCER GENE ATR LEADS DISRUPTION PK
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/195450
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1158/2159-8290.CD-20-0868